Long-term patient-reported outcomes after high-dose chemoradiotherapy for non-surgical management of distal rectal cancer.
Surgery is standard treatment for rectal cancer, but neoadjuvant chemoradiotherapy (CRT) may result in clinical complete response (cCR) in select patients, allowing for non-surgical management (NSM). Prospective studies of NSM strategies are sparse however, and long-term data on quality of life (QoL) are limited. We conducted a single-arm phase II trial of high-dose CRT for NSM of distal rectal cancer; we report secondary long-term patient-reported outcomes (PROs), local regrowth and overall survival (OS) in patients managed non-surgically. Fifty-one patients with resectable, T2 or T3, N0-N1, low adenocarcinoma received 65Gy (IMRT, brachytherapy boost) and oral tegafur-uracil. Patients with cCR 6 weeks after treatment (clinical examination, MRI, biopsy) were referred for observation, and followed closely with clinical examinations, endoscopies, PET-CTs, and PROs for 5 years. Overall colorectal cancer specific QoL and specific symptom scores were evaluated at baseline and in follow up, and compared between timepoints. Local regrowth was estimated using cumulative incidence; overall survival using Kaplan-Meier estimates. Forty patients achieved cCR after treatment; 29 were in follow-up at 24m, 21 at 36m, 20 at 60m. PRO questionnaire completion rates were 90% at 24 months, 100% at 36m, and 85% at 60m, respectively, for patients still in follow-up. Average QoL score did not differ between baseline (median 11.1) and 24m (13.7), 48m (11.1,) or 60m (6.9). Only rectal bleeding deteriorated from baseline, with bowel and bladder related symptom scores otherwise unchanged in follow-up. At median follow-up of 5.0 years, local regrowth rate and OS were 31% (95 CI 15%-47%) and 85% (95 CI 75%-97%), respectively. Long term follow-up after NSM of distal rectal cancer showed excellent general colorectal cancer QoL and local symptom scores. Our study results indicate that high dose CRT followed by organ preservation might be an alternative to standard treatment.